United Therapeutics Goodwill and Intangible Assets, Net decreased by 0.9% to $115.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.4%, from $111.70M to $115.50M. Over 5 years (FY 2020 to FY 2025), Goodwill and Intangible Assets, Net shows a downward trend with a -5.9% CAGR.
High levels indicate significant historical M&A activity; sudden decreases suggest impairment charges due to underperforming acquisitions.
This represents the excess of the purchase price over the fair value of net assets acquired in business combinations, pl...
Highly comparable across the banking sector, where consolidation through acquisitions is a common growth strategy.
goodwill_and_intangible_assets_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $44.70M | $44.70M | $44.60M | $44.60M | $44.60M | $44.50M | $44.50M | $44.50M | $44.50M | $44.40M | $114.20M | $115.40M | $115.20M | $112.10M | $111.90M | $111.70M | $111.50M | $116.70M | $116.50M | $115.50M |
| QoQ Change | — | +0.0% | -0.2% | +0.0% | +0.0% | -0.2% | +0.0% | +0.0% | +0.0% | -0.2% | +157.2% | +1.1% | -0.2% | -2.7% | -0.2% | -0.2% | -0.2% | +4.7% | -0.2% | -0.9% |
| YoY Change | — | — | — | — | -0.2% | -0.4% | -0.2% | -0.2% | -0.2% | -0.2% | +156.6% | +159.3% | +158.9% | +152.5% | -2.0% | -3.2% | -3.2% | +4.1% | +4.1% | +3.4% |